IDWeek On-Demand 2025

• Target Audience: infectious disease physicians, clinical pharmacists, infection preventionists, general practitioners & hospitalists
• Sample video: contact me for sample video
• Information:

IDWEEK ON-DEMAND 2025: THE COMPLETE INFECTIOUS DISEASES LIBRARY

“Advancing Science, Improving Care: The Global ID Authority”

General Information

IDWeek is not just a conference; it is the annual benchmark for the field of Infectious Diseases. It represents the combined intellectual power of the five major ID societies.

The On-Demand 2025 package is designed for the busy clinician who cannot be in five places at once. It transforms the chaotic live event into a structured, searchable Medical Course. This digital library grants you unlimited access to over 200 sessions, ensuring you never miss a pivotal update—from the “late-breaking” clinical trials to the granular debates on antibiotic dosing.

Target Audience

This comprehensive curriculum is mandatory for:

Infectious Disease Physicians: Who need to interpret the 2025 guidelines for multi-drug resistant organisms (MDROs).

Clinical Pharmacists: Especially those specializing in stewardship and PK/PD dynamics of new agents (cefiderocol, plazomicin, etc.).

Infection Preventionists: Dealing with hospital-acquired outbreaks and policy implementation.

General Practitioners & Hospitalists: Who manage complex infections on the wards and need “Cheat Sheets” for empiric therapy.

Learning Objectives

By engaging with the IDWeek 2025 content, participants will be able to:

Combat Resistance: Apply the latest IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections (2025 Updates).

Modernize HIV Care: Transition eligible patients to Long-Acting Injectable antiretroviral regimens and implement Doxy-PEP for STI prevention.

Navigate the “Tripledemic”: Master the co-management of COVID-19, Influenza, and RSV in both pediatric and adult populations.

Debunk Dogma: Evaluate the evidence behind “Shorter is Better” courses of therapy for pneumonia, bacteremia, and osteomyelitis.

Course Topics & Tracks (2025 Highlights)

TOPIC 1: The “Superbug” Summit (AMR)

New Drug Pipeline: Clinical data on the newest beta-lactam/beta-lactamase inhibitors.

Phage Therapy: Moving from experimental compassionate use to clinical trials.

Fungal Resistance: Managing Candida auris outbreaks in 2025.

TOPIC 2: HIV & Sexual Health

PrEP 3.0: Ultra-long-acting agents and implants.

Doxy-PEP: Implementation guidelines, resistance concerns, and real-world efficacy data.

Aging with HIV: Managing metabolic syndrome and cardiovascular risk in long-term survivors.

TOPIC 3: Clinical Controversies (The “Great Debates”)

Interactive Sessions where experts argue opposing sides:

“Oral vs. IV for Endocarditis: Have we gone too far?”

“Is Vancomycin dead for MRSA bacteremia?”

“Do we really need to treat asymptomatic bacteriuria in any population?”

TOPIC 4: Pediatric Focus (PIDS Track)

Congenital Syphilis: The rising crisis and management strategies.

Vaccine Hesitancy: New communication scripts for pediatricians.

RSV Prevention: Real-world data on the effectiveness of nirsevimab and maternal vaccination.

TOPIC 5: Diagnostic Stewardship

Rapid Diagnostics: Interpreting BioFire/PCR panels in hours, not days.

The “Culture-Negative” Patient: How to use Metagenomic Next-Generation Sequencing (mNGS) effectively without breaking the budget.